| Reconstructing kinase network topologies from phosphoproteomics data reveals cancer-associated rewiring M Hijazi, R Smith, V Rajeeve, C Bessant, PR Cutillas Nature Biotechnology 38 (4), 493-502, 2020 | 83 | 2020 |
| Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs H Gerdes, P Casado, A Dokal, M Hijazi, N Akhtar, R Osuntola, V Rajeeve, ... Nature communications 12 (1), 1850, 2021 | 74 | 2021 |
| Cancer burden is controlled by mural cell-β3-integrin regulated crosstalk with tumor cells PP Wong, JM Muñoz-Félix, M Hijazi, H Kim, SD Robinson, ... Cell 181 (6), 1346-1363. e21, 2020 | 62 | 2020 |
| Impact of phosphoproteomics in the translation of kinase‐targeted therapies P Casado, M Hijazi, D Britton, PR Cutillas Proteomics 17 (6), 1600235, 2017 | 33 | 2017 |
| Prediction of signed protein kinase regulatory circuits BM Invergo, B Petursson, N Akhtar, D Bradley, G Giudice, M Hijazi, ... Cell systems 10 (5), 384-396. e9, 2020 | 23 | 2020 |
| Overexpression of DYRK1A inhibits choline acetyltransferase induction by oleic acid in cellular models of Down syndrome M Hijazi, C Fillat, JM Medina, A Velasco Experimental neurology 239, 229-234, 2013 | 15 | 2013 |
| Targeting the lysine-specific demethylase 1 rewires kinase networks and primes leukemia cells for kinase inhibitor treatment F Pedicona, P Casado, M Hijazi, JG Gribben, K Rouault-Pierre, ... Science Signaling 15 (730), eabl7989, 2022 | 14 | 2022 |
| PARP-1 activation after oxidative insult promotes energy stress-dependent phosphorylation of YAP1 and reduces cell viability SM Martín-Guerrero, P Casado, M Hijazi, V Rajeeve, J Plaza-Díaz, ... Biochemical Journal 477 (23), 4491-4513, 2020 | 11 | 2020 |
| eEF2K activity determines synergy to cotreatment of cancer cells with PI3K and MEK inhibitors M Hijazi, P Casado, N Akhtar, S Alvarez-Teijeiro, V Rajeeve, PR Cutillas Molecular & Cellular Proteomics 21 (6), 2022 | 8 | 2022 |
| Restrained phosphatidylcholine synthesis in a cellular model of down’s syndrome is associated with the overexpression of DyRk1A M Hijazi, JM Medina, A Velasco Molecular neurobiology 54, 1092-1100, 2017 | 6 | 2017 |
| Implementation of clinical phosphoproteomics and proteomics for personalized medicine P Casado, M Hijazi, H Gerdes, PR Cutillas Clinical Proteomics: Methods and Protocols, 87-106, 2022 | 4 | 2022 |
| Oleic acid and cholinergic dysfunction in Down Syndrome models of the central nervous system AP Velasco Criado, M Hijazi Vega Journal of Neurology and Neuromedicine 1 (23), 1-5, 2016 | 2 | 2016 |
| Community detection in empirical kinase networks identifies new potential members of signalling pathways CDLAC Basanta, M Bazzi, M Hijazi, C Bessant, PR Cutillas PLOS Computational Biology 19 (6), e1010459, 2023 | 1 | 2023 |
| Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics L Prieto-Fernandez, M de los Angeles Villaronga, F Hermida-Prado, ... Biomedicine & Pharmacotherapy 158, 114176, 2023 | 1 | 2023 |
| Community detection in empirical kinase networks identifies new members of signaling pathways C De Los Angeles Colomina Basanta, M Bazzi, M Hijazi, C Bessant, ... bioRxiv, 2022.08. 04.502751, 2022 | | 2022 |
| Chemical phosphoproteomics systematically identifies circuitries of kinase networks in cancer cells and predicts their response to kinase inhibitors PR Cutillas, M Hijazi, R Smith, C Bessant, D Britton MOLECULAR CANCER THERAPEUTICS 18 (12), 2019 | | 2019 |
| Neuronal differentiation promoted by oleic acid is impaired in TgDyrk1A primary neuronal culture M Hijazi, C Fillat, JM Medina, A Velasco FEBS JOURNAL 279, 407-407, 2012 | | 2012 |
| Neuronal differentiation promoted by oleic acid is impaired in TgDyrk1A primary neuronal culture M Hijazi Vega, C Fillat, JM Medina Jiménez, AP Velasco Criado The FEBS Journal 279 (s1), 52-576, 2012 | | 2012 |
Pedro Rodriguez CutillasBarts Cancer Institute, Queen Mary University of LondonVerified email at qmul.ac.uk
